It should be noted that targeting the Mnk pathway represents an attractive target for the treatment of these cancers because Mnk activity – while being necessary for eIF4E-mediated oncogenic transformation – is dispensable for normal development [31]. The gene discussed is ATP7A; the disease is cancer.